Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

Louise M Paterson, Robin J Tyacke, David J Nutt, Gitte M Knudsen

    104 Citations (Scopus)

    Abstract

    Molecular in vivo neuroimaging techniques can be used to measure regional changes in endogenous neurotransmitters, evoked by challenges that alter synaptic neurotransmitter concentration. This technique has most successfully been applied to the study of endogenous dopamine release using positron emission tomography, but has not yet been adequately extended to other neurotransmitter systems. This review focuses on how the technique has been applied to the study of the 5-hydroxytryptamine (5-HT) system. The principles behind visualising fluctuations in neurotransmitters are introduced, with reference to the dopaminergic system. Studies that aim to image acute, endogenous 5-HT release or depletion at 5-HT receptor targets are summarised, with particular attention to studies in humans. Radiotracers targeting the 5-HT(1A), 5-HT(2A), and 5-HT(4) receptors and the serotonin reuptake transporter have been explored for their sensitivity to 5-HT fluctuations, but with mixed outcomes; tracers for these targets cannot reliably image endogenous 5-HT in humans. Shortcomings in our basic knowledge of the mechanisms underlying changes in binding potential are addressed, and suggestions are made as to how the selection of targets, radiotracers, challenge paradigms, and experimental design might be optimised to improve our chances of successfully imaging endogenous neurotransmitters in the future.
    Original languageEnglish
    JournalJournal of Cerebral Blood Flow and Metabolism
    Volume30
    Issue number10
    Pages (from-to)1682-706
    Number of pages25
    ISSN0271-678X
    DOIs
    Publication statusPublished - 1 Oct 2010

    Fingerprint

    Dive into the research topics of 'Measuring endogenous 5-HT release by emission tomography: promises and pitfalls'. Together they form a unique fingerprint.

    Cite this